Abstract

Glofitamab Monotherapy Provides Durable Responses after Fixed-Length Dosing in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (pts)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Glofitamab Step-up Dosing Induces High Response Rates in Patients (pts) with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL), Most of Whom Had Failed Prior Bruton's Tyrosine Kinase Inhibitor (BTKi) Therapy
James Relf ... Linda Lundberg
Blood | VOL. 138
James Relf, et. al.James Relf ... Linda Lundberg
05 Nov 2021
Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results from a Phase I/II Study
Michelle Y Doral ... Nancy L Bartlett
Blood | VOL. 138
Michelle Y Doral, et. al.Michelle Y Doral ... Nancy L Bartlett
05 Nov 2021
The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
Richard Greil ... Adrien Chauchet
Blood | VOL. 138
Richard Greil, et. al.Richard Greil ... Adrien Chauchet
04 Dec 2021
Glofitamab Plus R-CHOP Induces High Response Rates with Minimal Cytokine Release Syndrome (CRS) in Patients (pts) with Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and Previously Untreated (1L) Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results from a Dose-Escalation and Safety Run-in Phase Ib Study
Michael Dickinson ... Steven Le Gouill
Blood | VOL. 138
Michael Dickinson, et. al.Michael Dickinson ... Steven Le Gouill
05 Nov 2021
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies
Matthew J Frigault ... Marcela V Maus
Blood | VOL. -
Matthew J Frigault, et. al.Matthew J Frigault ... Marcela V Maus
23 May 2024
IL-1 in Aging and Pathologies of Hematopoietic Stem Cells
Francisco Caiado ... Markus G Manz
Blood | VOL. -
Francisco Caiado, et. al.Francisco Caiado ... Markus G Manz
23 May 2024
Rapid Tumor DNA Analysis of Cerebrospinal Fluid Accelerates Treatment of Central Nervous System Lymphoma
Mihir Gupta ... Ganesh M Shankar
Blood | VOL. -
Mihir Gupta, et. al.Mihir Gupta ... Ganesh M Shankar
22 May 2024
Targeting the tumor microenvironment for treating double refractory chronic lymphocytic leukemia
Richard Ian Lewis ... Michael J Hallek
Blood | VOL. -
Richard Ian Lewis, et. al.Richard Ian Lewis ... Michael J Hallek
22 May 2024
View more papers